Cargando…
Evaluation of 4 prognostic indices in follicular lymphoma treated in first line with immunochemotherapy
Several clinical risk models have been proposed to predict the outcome of follicular lymphoma (FL). The development of next-generation sequencing technologies has allowed the integration of somatic gene mutations into clinical scores to build genotyped-based risk models, such as the m7–Follicular Ly...
Autores principales: | Rodríguez-Sevilla, Juan Jose, Fernández-Rodríguez, Concepción, Bento, Leyre, Diez-Feijóo, Ramón, Pinzón, Sergio, Gibert, Joan, Fernández-Ibarrondo, Lierni, Lafuente, Marta, Ferrer, Ana, Sánchez-González, Blanca, Gimeno, Eva, Sainz, Juan, Ramos, Rafael, García, Juan F., Colomo, Lluis, Bellosillo, Beatriz, Gutiérrez, Antonio, Salar, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173729/ https://www.ncbi.nlm.nih.gov/pubmed/36260737 http://dx.doi.org/10.1182/bloodadvances.2022007949 |
Ejemplares similares
-
Sézary syndrome patient–derived models allow drug selection for personalized therapy
por: Gallardo, Fernando, et al.
Publicado: (2022) -
Evolving frontline immunochemotherapy for mantle cell lymphoma and the impact on survival outcomes
por: Castellino, Alessia, et al.
Publicado: (2022) -
Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapy
por: Baech, Joachim, et al.
Publicado: (2022) -
Worse outcome and distinct mutational pattern in follicular lymphoma with anti-HBc positivity
por: Fernández-Rodríguez, Concepción, et al.
Publicado: (2022) -
Immunochemotherapy or chemotherapy alone in primary central nervous system lymphoma: a National Cancer Database analysis
por: Ollila, Thomas A., et al.
Publicado: (2023)